Daniel I. Simon, M.D. أُعيد تغريده

Patients suffering from refractory ventricular tachycardia who are not suitable for existing treatment options now have another potential avenue for recovery thanks to a promising novel offering from UH Harrington Heart & Vascular Institute. bit.ly/HHVIX426
English
























